Skip to content
lifestyle.tasteterminal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
XVIVO Perfusion AB
Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO’s Heart Technology
May 24, 2026
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
May 20, 2026
Interim Report January – March 2026
May 20, 2026
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 29, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 29, 2026
Conference Call on Interim Report January-March 2026
April 17, 2026
The 12-Month Follow-up Results from XVIVO’s European Multicenter Heart Trial is Now Published in the European Heart Journal
April 16, 2026
Annual Report 2025
April 1, 2026
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)
March 19, 2026
CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members
February 20, 2026
1
2
Next Page
→